| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |